Feb 23 (Reuters) - Eli Lilly (LLY.N), opens new tab said on Monday it received the U.S. Food and Drug Administration's approval to launch a four-dose KwikPen for its weight-loss drug Zepbound, ...
Image-2, a text-to-image model ranking third on the Arena leaderboard, but daily caps and square-only output limit its appeal.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results